According to Zhitong Finance App, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The Group is the first domestic company to obtain drug production registration approval from the China National Drug Administration (CFDA) for methobamol tablets (0.5g). It is a category 3 chemical drug, which is considered to have passed the consistency evaluation. Mesobamol tablets are a muscle relaxant, mainly used for conditions such as joint muscle sprains, lumbar strain, and sciatica.

According to Zhitong Finance App, Shisi Pharmaceutical Group (02005.HK) issued an announcement. The Group is the first domestic company to obtain drug production registration approval from the China National Drug Administration (CFDA) for methobamol tablets (0.5g). It is a category 3 chemical drug, which is considered to have passed the consistency evaluation. Mesobamol tablets are a muscle relaxant, mainly used for conditions such as joint muscle sprains, lumbar strain, and sciatica.